Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in Uncomplicated Symptomatic Diverticular Disease
NCT02068482Phase 4Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Nov 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifaximin in diverticular disease, sponsored by Università Cattolica del Sacro Cuore. Started Nov 2010; status: completed.
02
Drugs
rifaximin
03
Conditions
diverticular disease
Beyond the preview
Go deeper on NCT02068482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068482.